On December 6, 2022, Dr. Karen Reeves informed the Board of Directors of Kiromic BioPharma, Inc. that she was resigning her position as a director of the Registrant, effective immediately. Dr. Reeves also ceased to be a member of the Nominating and Corporate Governance Committee, and the Compensation Committee of the Board. Dr. Reeves' resignation did not involve a disagreement with the Registrant on any matter relating to the Registrant's operations, policies or practices.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.819 USD | +2.88% | -11.35% | +224.02% |
06-07 | Kiromic Biopharma, Inc. Issues 25% Senior Secured Convertible Promissory Note | CI |
06-03 | Kiromic BioPharma, Inc. announced that it has received $2 million in funding | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+224.02% | 4.35M | |
+18.52% | 125B | |
+14.08% | 108B | |
-6.55% | 23.64B | |
+2.39% | 22.39B | |
-12.11% | 17.78B | |
-41.64% | 16.43B | |
-14.98% | 16.34B | |
+0.29% | 13.56B | |
+25.38% | 11.59B |
- Stock Market
- Equities
- KRBP Stock
- News Kiromic BioPharma, Inc.
- Kiromic Biopharma, Inc. Announces Resignation of Karen Reeves as Director